Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
American Finest (AF) is a biotechnology company and specialized contract manufacturer focused on the high-purity extraction and refinement of hemp-derived cannabinoids. Based in North Carolina, the company utilizes proprietary industrial-scale chromatography platforms to produce THC-free isolates and distillates, including CBD, CBG, and CBN, which serve as Active Pharmaceutical Ingredients (APIs) for the global healthcare and wellness industries. Beyond its focus on botanical extracts, American Finest also manufactures a line of FDA-cleared personal protective equipment (PPE), including medical-grade surgical masks. The company is recognized for its science-first approach to cannabinoid production, emphasizing transparency, purity, and regulatory compliance to support clinical research and pharmaceutical product development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American Finest.